ZSTK474MedChemExpress (MCE)美国ZSTK474 是一种 ATP 竞争性的泛 I 类 PI3K 抑制剂,抑制 PI3Kα,PI3Kβ,PI3Kδ 和 PI3Kγ,IC50 分别为 16 nM,44 nM,4.6
ZSTK474TargetMol美国生化试剂,可用于动物细胞实验Product IntroductionBioactivity英文名: ZSTK474描述: ZSTK474 是 ATP 竞争性的泛 I 类PI3K 抑制剂,抑制 PI3K
阿拉丁上海 分子式 C19H21F2N7O2
酰胺化合物,是一种ZSTK474 类似物,对 HeLa细胞显示出抗癌活性。存储条件: store at low temperaturePowder: -20°C for 3 years | In solvent: -80°C for 1 year
| 740 Y-P acetate | Copanlisib | ZSTK474 | Vacuolin-1 | Duvelisib (R enantiomer) hydrochloride | Zandelisib相关库: Antioxidant
: Enzastaurin | Rotenone | Luteolin | MRT68921 dihydrochloride | Imatinib | Corynoxine B | Biochanin A | Berberine | ZSTK474
| 3-Methyladenine | 8-Prenylkaempferol | ZSTK474相关库: Antioxidant Compound Library | Anti-Prostate Cancer Compound Library
| YH-306 | (2S,3R,4S)-4-Hydroxyisoleucine | Ginsenoside Rk1 | STX-478 | Jolkinolide B | Voxtalisib | ZSTK474
| Idelalisib | ZSTK474 | Umbralisib hydrochloride相关库: Anti-Aging Compound Library | Anti-Breast Cancer Compound Library
), and ZSTK474 (1 μM), and Rapamycin (100 nM). Compound concentrations are set 2 log units above the IC50 in vitro to ensure full
效能为先,平稳运营|安捷伦InfinityLab消耗品交流会暨新品预发布
永道致远重磅发布质谱新品 开启精准分析新篇章
创新引领未来 | 安捷伦智能化气相色谱新品重磅发布
咨询热线: 010-84839035
联系邮箱: sales@antpedia.net